title: E. coli crisis opens door for Alexion drug trial.
authors.forename: Lucas
authors.initials: L
authors.lastname: Laursen
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004196:Disease Outbreaks; D017277:Drug Approval; D054324:Enterohemorrhagic Escherichia coli / Q000302:isolation & purification*; D004927:Escherichia coli Infections / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans
chemical_list: D061067:Antibodies, Monoclonal, Humanized; C481642:eculizumab